Heart failure in thyrotoxicosis, an approach to management.
作者信息
Choudhury R P, MacDermot J
机构信息
Section on Clinical Pharmacology, Imperial College School of Medicine, Hammersmith Hospital, London.
出版信息
Br J Clin Pharmacol. 1998 Nov;46(5):421-4. doi: 10.1046/j.1365-2125.1998.00804.x.
Abstract
摘要
相似文献
1
Heart failure in thyrotoxicosis, an approach to management.甲状腺毒症性心力衰竭的治疗方法
Br J Clin Pharmacol. 1998 Nov;46(5):421-4. doi: 10.1046/j.1365-2125.1998.00804.x.
2
Thyrotoxicosis and the cardiovascular system: subtle but serious effects.甲状腺毒症与心血管系统：细微却严重的影响。
Cleve Clin J Med. 2003 Jan;70(1):57-63. doi: 10.3949/ccjm.70.1.57.
3
Thyrotoxicosis presenting as acute bulbar palsy.以急性球麻痹为表现的甲状腺毒症
J Assoc Physicians India. 2011 Jun;59:386-7.
4
Lingual dyskinesia in hyperthyroidism.甲状腺功能亢进症中的舌运动障碍。
BMJ Case Rep. 2017 Dec 7;2017:bcr-2017-223226. doi: 10.1136/bcr-2017-223226.
5
[Chronic heart failure and atrial fibrilation: aspects of management].
Kardiologiia. 2003;43(10):87-92.
6
Digoxin in patients with heart failure.
N Engl J Med. 1997 Jul 10;337(2):129-30; author reply 130-1.
7
Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature.一名年轻女性的甲状腺毒症与双侧下肢轻瘫：病例报告及文献综述
Thyroid. 2002 Jan;12(1):77-80. doi: 10.1089/105072502753452002.
8
Pericardial effusion and tamponade complicating treated graves' thyrotoxocosis.心包积液和心脏压塞并发于经治疗的格雷夫斯甲状腺毒症。
Ulster Med J. 2009 Jan;78(1):56-7.
9
Ivabradine in heart failure: what about digoxin?
Lancet. 2008 Dec 20;372(9656):2113; author reply 2113-4. doi: 10.1016/S0140-6736(08)61923-6.
10
Carbimazole--resistant thyrotoxicosis.卡比马唑耐药性甲状腺毒症
Postgrad Med J. 1997 Oct;73(864):686. doi: 10.1136/pgmj.73.864.686.
引用本文的文献
1
Echocardiography used for treatment in heart failure accompanied by thyroid storm: Case report and literature review.超声心动图用于治疗伴有甲状腺危象的心力衰竭：病例报告及文献综述
Clin Case Rep. 2024 Aug 5;12(8):e9234. doi: 10.1002/ccr3.9234. eCollection 2024 Aug.
2
Thyrotoxic Cardiomyopathy: State of the Art.甲状腺毒症性心肌病：最新进展
touchREV Endocrinol. 2023 May;19(1):78-84. doi: 10.17925/EE.2023.19.1.78. Epub 2023 Feb 7.
3
Cardio-Thyrotoxicosis Syndrome: A Review of Thyrotoxic Cardiovascular Disease.心脏甲状腺毒症综合征：甲状腺毒症性心血管疾病综述
Cureus. 2023 Apr 16;15(4):e37659. doi: 10.7759/cureus.37659. eCollection 2023 Apr.
4
Thyrotoxicosis-Induced Cardiomyopathy With Systolic Dysfunction.甲状腺毒症性心肌病伴收缩功能障碍
Cureus. 2023 Jan 20;15(1):e33988. doi: 10.7759/cureus.33988. eCollection 2023 Jan.
5
Resolution of Thyrotoxicosis-Associated Pulmonary Hypertension With Treatment of Thyrotoxicosis: A Case-Based Report and Literature Review.甲状腺毒症相关肺动脉高压经甲状腺毒症治疗后缓解：一例报告及文献综述
Cureus. 2022 Jan 16;14(1):e21304. doi: 10.7759/cureus.21304. eCollection 2022 Jan.
6
Clinical phenotypes and prognosis of thyrotoxic heart failure and cardiomyopathy in patients hospitalized for acute heart failure.住院治疗急性心力衰竭患者中甲状腺功能亢进性心力衰竭和心肌病的临床表型和预后。
ESC Heart Fail. 2021 Aug;8(4):2776-2783. doi: 10.1002/ehf2.13347. Epub 2021 May 1.
7
Thyroid and Cardiovascular Disease: A Focused Review on the Impact of Hyperthyroidism in Heart Failure.甲状腺与心血管疾病：关于甲状腺功能亢进对心力衰竭影响的重点综述
Cardiol Res. 2020 Apr;11(2):68-75. doi: 10.14740/cr1034. Epub 2020 Mar 10.
8
Management of Cardiogenic Shock due to Thyrotoxicosis: A Systematic Literature Review.甲状腺毒症性心原性休克的治疗：系统文献回顾。
Curr Cardiol Rev. 2020;16(4):326-332. doi: 10.2174/1573403X16666200313103657.
9
A Case Report of Dilated Biventricular Heart Failure from Hyperthyroidism: A Rare Presentation.一例甲状腺功能亢进所致双心室扩张型心力衰竭的病例报告：一种罕见的表现。
Cureus. 2018 Apr 2;10(4):e2410. doi: 10.7759/cureus.2410.
10
Hyperthyroidism and the Heart.甲状腺功能亢进与心脏
Methodist Debakey Cardiovasc J. 2017 Apr-Jun;13(2):60-63. doi: 10.14797/mdcj-13-2-60.
本文引用的文献
1
2
ELECTROCARDIOGRAPHIC FINDINGS AMONG THE ADULT POPULATION OF A TOTAL NATURAL COMMUNITY, TECUMSEH, MICHIGAN.密歇根州蒂康西一个完整自然社区成年人群的心电图检查结果
Circulation. 1965 Jun;31:888-98. doi: 10.1161/01.cir.31.6.888.
3
The pure form of thyrotoxic heart disease; a clinical and pathological study.
Am J Cardiol. 1958 Oct;2(4):430-40. doi: 10.1016/0002-9149(58)90329-1.
4
Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone.口服胺碘酮治疗心房颤动和心房扑动的疗效、安全性及转复的决定因素
Am J Cardiol. 1997 Jan 1;79(1):53-7. doi: 10.1016/s0002-9149(96)00675-3.
5
Effects of amiodarone on thyroid function.胺碘酮对甲状腺功能的影响。
Ann Intern Med. 1997 Jan 1;126(1):63-73. doi: 10.7326/0003-4819-126-1-199701010-00009.
6
Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias.静脉注射胺碘酮对于终止阵发性室上性快速心律失常是安全且似乎有效的。
Clin Cardiol. 1996 Jul;19(7):563-6. doi: 10.1002/clc.4960190708.
7
Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.胺碘酮的抗心律失常作用：一种矛盾药物的剖析
Am J Cardiol. 1996 Aug 29;78(4A):41-53. doi: 10.1016/s0002-9149(96)00452-3.
8
Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study.静脉注射胺碘酮治疗近期发作的心房颤动：一项随机对照研究的结果
J Am Coll Cardiol. 1996 Apr;27(5):1079-82. doi: 10.1016/0735-1097(95)00595-1.
9
Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.使用超短效β受体阻滞剂艾司洛尔的临床依据。
Int J Clin Pharmacol Ther. 1995 Apr;33(4):212-8.
10
Left ventricular function and hyperthyroidism.左心室功能与甲状腺功能亢进
Br Heart J. 1981 Aug;46(2):137-43. doi: 10.1136/hrt.46.2.137.
Zotero 插件